SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-360454
Filing Date
2017-12-05
Accepted
2017-12-04 19:03:03
Documents
8
Period of Report
2017-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d495508d8k.htm 8-K 22003
2 EX-99.1 d495508dex991.htm EX-99.1 9609
3 EX-99.2 d495508dex992.htm EX-99.2 9605
4 EX-99.3 d495508dex993.htm EX-99.3 28690
5 EX-99.4 d495508dex994.htm EX-99.4 29289
6 GRAPHIC g495508g1202225318044.jpg GRAPHIC 4357
7 GRAPHIC g495508g1202225905924.jpg GRAPHIC 4357
8 GRAPHIC g495508snap0001.jpg GRAPHIC 1819
  Complete submission text file 0001193125-17-360454.txt   115505
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 171238333
SIC: 2834 Pharmaceutical Preparations